Cardiology Practice Questions

Q: Duroziez's sign is associated with which of the following conditions?

Aortic Regurgitation. ***Aortic Regurgitation*** - **Duroziez's sign** is a characteristic **systolic and diastolic bruit** heard over the femoral artery, indicative of significant **aortic regurgitation**. [1], [2] - This sign occurs due to the rapid antegrade and retrograde flow of blood during systole and diastole, respectively, caused by the incompetent aortic valve. [2] *Tricuspid Regurgitation* - **Tricuspid regurgitation** is primarily associated with **holosystolic murmur** best heard at the left lower sternal border, often increasing with inspiration (Carvallo's sign). - It does not produce arterial bruits like Duroziez's sign. *Pericardial effusion* - **Pericardial effusion** is characterized by the accumulation of fluid in the pericardial sac, which can lead to distant heart sounds, **pulsus paradoxus**, and electrical alternans on ECG. - It does not involve vascular bruits in peripheral arteries. *Mitral Stenosis* - **Mitral stenosis** classically presents with a **diastolic rumble** and an **opening snap**, typically heard at the apex. - It is a left-sided heart valve condition that does not cause peripheral arterial bruits.

Q: In the context of chest pain evaluation, which is the best way to differentiate between stable angina and NSTEMI?

Cardiac-biomarker. **Cardiac-biomarker** - **Cardiac biomarkers**, particularly **troponin**, are crucial for differentiating between **unstable angina** and **NSTEMI** [1], [2]. In NSTEMI, there is evidence of **myocardial necrosis**, leading to elevated cardiac troponins [2]. - **Stable angina** and **unstable angina** do not involve myocardial necrosis, so troponin levels remain within the normal range [1]. *ECG* - While an **ECG** is essential in the initial assessment of chest pain, it may show **non-specific changes** in both **unstable angina** and **NSTEMI**, such as T-wave inversions or ST-segment depression [2]. - The definitive distinction of **NSTEMI** often relies on **sequential biomarker measurements**, as ECG changes alone may not be sufficient for diagnosis or differentiation from unstable angina [2]. *Trans thoracic Echocardiography* - **Echocardiography** can show **regional wall motion abnormalities** that might suggest ischemia, but these findings are not specific enough to differentiate between **stable angina** and **NSTEMI** immediately. - It is more useful for assessing **ventricular function**, identifying **valvular disease**, or detecting other causes of chest pain, rather than acute differentiation of coronary syndromes. *Multi uptake gated Acquisition scan* - A **MUGA scan** assesses **left ventricular ejection fraction** and wall motion, primarily used in evaluating global cardiac function and monitoring cardiotoxicity from chemotherapy. - It is **not a first-line diagnostic tool** for differentiating between acute coronary syndromes like **stable angina** and **NSTEMI** because it does not directly detect acute myocardial injury.

Q: Among the following emerging risk factors, which is considered the most important predisposing factor for coronary artery disease?

↑ Lipoprotein(a). ***↑ Lipoprotein(a)*** - **Lipoprotein(a) [Lp(a)]** is an **independent and causal risk factor** for **Coronary Artery Disease (CAD)**, with its elevated levels strongly associated with increased cardiovascular risk. - Its proatherogenic and prothrombotic properties, attributed to its structural similarity to **LDL** and **plasminogen**, make it a particularly potent emerging risk factor. *Homocysteinemia* - While **elevated homocysteine levels** are associated with increased risk of **atherosclerosis** and **thrombosis**, the evidence for it as an independent causal risk factor for **CAD** is weaker compared to Lp(a). - Its contribution to **CAD** risk is often considered in the context of other traditional risk factors and may be influenced by nutrient deficiencies like **folate** and **B vitamins**. *↑ Fibrinogen* - **Elevated fibrinogen levels** are a marker of **inflammation** and are associated with an increased risk of **CAD** due to its role in **blood coagulation** and **platelet aggregation** [1]. - However, fibrinogen is considered more of a **risk marker** and a component of the inflammatory response rather than a primary, independent causal factor like Lp(a). *↑ plasminogen activator inhibitors 1* - **Elevated plasminogen activator inhibitor-1 (PAI-1)** levels promote a **prothrombotic state** by inhibiting **fibrinolysis**, which can contribute to the development of **CAD**. - While important in the pathophysiology of **thrombosis**, it is generally considered a downstream mediator in the context of vascular injury and inflammation, rather than the most significant emerging predisposing factor compared to Lp(a).

Q: Becks triad is seen in

Cardiac tamponade. ***Cardiac tamponade*** - **Beck's triad** is a set of three clinical signs associated with acute cardiac tamponade: **hypotension**, **jugular venous distension (JVD)**, and **muffled heart sounds**. [1] - These signs result from the accumulation of fluid in the pericardial sac, which compresses the heart and impairs its ability to fill. [1] *Constrictive pericarditis* - While it can manifest with JVD and signs of right heart failure, **muffled heart sounds** and acute **hypotension** as part of Beck's triad are not typical for its chronic nature. [2] - It involves a rigid, fibrotic pericardium that restricts diastolic filling, often with a **pericardial knock** rather than muffled sounds. [2] *Restrictive cardiomyopathy* - This condition involves impaired ventricular relaxation and filling, leading to signs of heart failure, including JVD. [3] - However, it does not typically present with the acute, severe **hypotension** or **muffled heart sounds** characteristic of cardiac tamponade. [3] *None of the options* - This option is incorrect as cardiac tamponade is the condition associated with Beck's triad.

Q: Digitalis is used in mitral stenosis to control the ventricular rate when the patient develops which condition?

Atrial fibrillation. ***Atrial fibrillation*** - **Digitalis** (digoxin) is effective in **slowing the ventricular rate** in atrial fibrillation by increasing vagal tone and prolonging the refractory period of the AV node. - In **mitral stenosis**, an uncontrolled rapid ventricular rate due to atrial fibrillation can significantly reduce cardiac output and worsen symptoms. *Right ventricular failure* - While digitalis can improve contractility, its primary role in **RV failure** is not rate control; diuretics and afterload reduction are more commonly used. - A patient with isolated right ventricular failure due to mitral stenosis would not directly benefit from digitalis for rate control. *Acute pulmonary edema* - **Acute pulmonary edema** requires rapid diuresis, oxygen, and vasodilators to reduce preload and afterload. - Digitalis has a slower onset of action and is not the first-line treatment for acute pulmonary edema, especially if the cause is not related to a rapid ventricular rate. *Myocarditis* - **Myocarditis** is an inflammation of the heart muscle, and digitalis is generally avoided due to concerns about potentially worsening arrhythmias and myocardial damage in an inflamed heart. - Treatment for myocarditis focuses on supportive care and addressing the underlying cause, not rate control with digitalis unless specific arrhythmias develop.

Q: Which of the following is not recommended for patients with coronary artery disease?

Vitamin E. ***Vitamin E*** - **Vitamin E supplements** are generally not recommended for patients with coronary artery disease (CAD) based on current evidence. Some studies suggest a potential link between high doses of vitamin E and an increased risk of **heart failure** or even **overall mortality**. - There is no convincing evidence that vitamin E supplements provide cardiovascular benefits in patients with established CAD, and they may interfere with the efficacy of other beneficial medications like **statins**. *Daily exercise* - **Regular physical activity** is a cornerstone of CAD management, improving cardiovascular fitness, reducing blood pressure, and aiding in weight control [1]. - It helps in preventing disease progression and reducing the risk of future cardiovascular events when performed under appropriate medical guidance [1]. *Potassium* - Maintaining adequate **potassium levels** is crucial for patients with CAD, especially those on diuretics, as it helps regulate **blood pressure** and prevents **cardiac arrhythmias**. - Dietary sources of potassium (fruits, vegetables) are preferred, and supplementation may be necessary for those with deficiencies, but always under medical supervision. *Statins* - **Statins** are a class of medications widely recommended for patients with CAD due to their ability to significantly lower **LDL cholesterol** levels and reduce cardiovascular events [1]. - They stabilize **atherosclerotic plaques** and reduce inflammation, playing a critical role in secondary prevention of heart attacks and strokes [1].

Q: Which of the following statements about atrial myxomas is correct?

Most commonly found in the Left Atrium.. ***Most commonly found in the Left Atrium.*** - **Atrial myxomas** are typically found in the **left atrium** (approximately 75-80% of cases), often attached to the **interatrial septum** near the fossa ovalis. - Their presence in the left atrium can lead to **obstruction of the mitral valve**, causing symptoms mimicking mitral stenosis [1]. *More prevalent in males.* - **Atrial myxomas** are more common in **females** than males, with a female-to-male ratio of approximately 2:1. - This higher prevalence in women is a consistent finding in epidemiological studies of cardiac myxomas [2]. *Most myxomas are hereditary.* - The vast majority of **atrial myxomas** are **sporadic** (non-hereditary), accounting for about 90-95% of cases. - A small percentage (5-10%) are part of a familial syndrome known as **Carney complex**, which is an autosomal dominant disorder. *Distant metastasis is commonly observed.* - **Atrial myxomas** are generally **benign tumors** and do not metastasize to distant sites. - While they can embolize fragments, leading to systemic effects, these are not true metastases.

Q: Which of the following is not typically used for secondary prevention of myocardial infarction?

Warfarin. ***Warfarin*** - While Warfarin is an **anticoagulant**, its primary role is in preventing *thromboembolism* in conditions like **atrial fibrillation** [1] or **mechanical heart valves**, not routinely for general **secondary prevention of MI** unless specific indications exist. - Unlike the other options, it doesn't directly address the underlying plaque rupture or reduce the workload of the heart in the typical post-MI patient. *Aspirin* - **Aspirin** is a cornerstone of secondary prevention after MI due to its **antiplatelet** effects, which help prevent future clot formation [2]. - It reduces the risk of recurrent MI, stroke, and cardiovascular death by inhibiting **platelet aggregation** [2]. *Statins* - **Statins** are crucial for secondary prevention as they aggressively lower **LDL cholesterol** levels, stabilizing existing plaques and preventing further plaque progression. - They have pleiotropic effects beyond lipid lowering, including **anti-inflammatory** and **endothelial function improvement**. *Beta blockers* - **Beta blockers** reduce myocardial oxygen demand by decreasing heart rate and contractility, which helps prevent recurrent ischemic events and improves survival post-MI [3]. - They are particularly beneficial in patients with **left ventricular dysfunction** or **hypertension** following an MI [1].

Q: In a patient with heart disease, which condition is most commonly associated with left atrial enlargement?

Mitral stenosis. ***Mitral stenosis*** - **Mitral stenosis** leads to an obstruction of blood flow from the **left atrium to the left ventricle**, causing pressure buildup in the left atrium [1]. - This increased pressure over time results in **left atrial enlargement** as the chamber struggles to push blood through the narrowed valve [1]. *Tricuspid regurgitation* - **Tricuspid regurgitation** involves the backflow of blood from the **right ventricle to the right atrium**. - This condition primarily affects the **right side of the heart**, leading to **right atrial enlargement**, not left. *AR* - **Aortic regurgitation (AR)** is the backflow of blood from the **aorta into the left ventricle**. - While AR can cause **left ventricular enlargement** and eventually lead to left atrial dilation, it is not the most common direct cause of *primary* left atrial enlargement compared to mitral stenosis [2]. *None of the options* - **Mitral stenosis** is a well-established cause of significant left atrial enlargement due to the direct pressure overload it imposes on the left atrium [1].

Q: Refer to the provided ECG image. It demonstrates which of the following?

Ventricular fibrillation (VF). ***Ventricular fibrillation (VF)*** - The ECG shows a chaotic, **irregular electrical activity** with no distinguishable P waves, QRS complexes, or T waves. - This disorganized electrical pattern is characteristic of VF, indicating a severe cardiac emergency. *Supraventricular tachycardia (SVT)* - SVT is characterized by a **rapid, regular rhythm** with narrow QRS complexes, which are absent in this chaotic tracing. - While fast, SVT typically maintains some degree of organized electrical activity, unlike the provided ECG. *Atrial fibrillation (AF)* - AF presents with irregularly irregular rhythm and **absent P waves**, but it still has identifiable **narrow QRS complexes**. - The provided ECG lacks any discernible QRS complexes, making AF an unlikely diagnosis. *Wolff-Parkinson-White (WPW) syndrome* - WPW syndrome is characterized by a **short PR interval** and a **delta wave** on the ECG due to an accessory pathway. - It involves an organized rhythm, although it can predispose to tachyarrhythmias, and doesn't present as the chaotic rhythm shown.

Question 1

Duroziez's sign is associated with which of the following conditions?

Accepted Answer

Aortic Regurgitation

Answer

Pericardial effusion

Answer

Tricuspid Regurgitation

Answer

Mitral Stenosis

Question 2

In the context of chest pain evaluation, which is the best way to differentiate between stable angina and NSTEMI?

Accepted Answer

Cardiac-biomarker

Answer

ECG

Answer

Trans thoracic Echocardiography

Answer

Multi uptake gated Acquisition scan

Question 3

Among the following emerging risk factors, which is considered the most important predisposing factor for coronary artery disease?

Accepted Answer

↑ Lipoprotein(a)

Answer

Homocysteinemia

Answer

↑ Fibrinogen

Answer

↑ plasminogen activator inhibitors 1

Question 4

Becks triad is seen in

Accepted Answer

Cardiac tamponade

Answer

Restrictive cardiomyopathy

Answer

Constrictive pericarditis

Answer

None of the options

Question 5

Digitalis is used in mitral stenosis to control the ventricular rate when the patient develops which condition?

Accepted Answer

Atrial fibrillation

Answer

Right ventricular failure

Answer

Acute pulmonary edema

Answer

Myocarditis

Question 6

Which of the following is not recommended for patients with coronary artery disease?

Accepted Answer

Vitamin E

Answer

Potassium

Answer

Statins

Answer

Daily exercise

Question 7

Which of the following statements about atrial myxomas is correct?

Accepted Answer

Most commonly found in the Left Atrium.

Answer

More prevalent in males.

Answer

Most myxomas are hereditary.

Answer

Distant metastasis is commonly observed.

Question 8

Which of the following is not typically used for secondary prevention of myocardial infarction?

Accepted Answer

Warfarin

Answer

Aspirin

Answer

Statins

Answer

Beta blockers

Question 9

In a patient with heart disease, which condition is most commonly associated with left atrial enlargement?

Accepted Answer

Mitral stenosis

Answer

Tricuspid regurgitation

Answer

AR

Answer

None of the options

Question 10

Refer to the provided ECG image. It demonstrates which of the following?

Accepted Answer

Ventricular fibrillation (VF)

Answer

Supraventricular tachycardia (SVT)

Answer

Atrial fibrillation (AF)

Answer

Wolff-Parkinson-White (WPW) syndrome

Cardiology — MCQs

Cardiology — MCQs

On this page

Practice by Chapter

Want unlimited practice?